HOME >> MEDICINE >> NEWS
UNC physicians seeking patients for blood clot, medication studies

CHAPEL HILL - Doctors at the University of North Carolina at Chapel Hill are seeking adults with acute pulmonary embolism or deep-vein thrombosis to participate in studies aimed at improving treatments for blood clots.

Dr. Stephan Moll, director of the thrombophilia program at the UNC School of Medicine's Center for Thrombosis and Hemostasis, said the studies will help determine the best way to prevent blood clot recurrence.

Coumadin, known generically as warfarin, is the standard blood-thinning medication doctors use to treat patients during the first six months after a blood clot is diagnosed, Moll said. However, the drug presents risks, and it topped UNC's recent list of medications with the most reported side effects.

"We don't like to give Coumadin long-term," he said. "It carries the risk of bleeding and can have side effects that range from mild bruising to death through bleeding in the head. On the other hand, we know that 25 percent of blood clot patients develop a second clot, and we want to avoid that. We're forced to weigh this risk against the risk of serious side effects from Coumadin, and that's not an optimal answer."

The first study, called PREVENT, is a randomized, double-blind trial that involves two groups of patients, Moll said. One group will receive no more Coumadin after the first six months but instead an inactive compound. A second group will follow the six months' regular treatment with a smaller maintenance dose of the drug. Both groups will be monitored for four years.

"We want to know if the lower dose, which we think decreases the risk of bleeding, actually prevents the recurrence of clots," Moll said. "If so, that dose should be the standard of care for patients with a first blood clot."

Moll is following 10 patients in the PREVENT study and would like to enroll as many as 50 more. Those eligible are age 30 and older who have had a blood clot -- not from surgery or trauma -- and
'"/>

Contact: David Williamson
David_Williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
26-Jun-2001


Page: 1 2 3

Related medicine news :

1. UW study shows blacks and Latinos are more satisfied with physicians of the same race
2. Balance and better interactions between primary-care and specialist physicians improve US health
3. Northwestern Memorial physicians encourage screenings during colon cancer awareness month
4. Common schizophrenia symptoms often overlooked by physicians, according to expert panel
5. New research could help physicians tailor asthma therapy in children
6. Communication between primary-care physicians and patients can reduce medication-related problems
7. Birth simulator helps physicians I.D. least forceful way to manage problem deliveries
8. Pharmaceutical marketing tactics hold little sway with prescribing physicians
9. Studies reveal physicians attitudes on end-of-life care
10. Imaging tool may help physicians diagnose bipolar disorder
11. White physicians slower to prescribe HIV medications for African-Americans than for whites

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UNC physicians seeking patients for blood clot medication studies

(Date:5/25/2013)... (PRWEB) May 25, 2013 On May 20, ... people do not wish to discuss or plan for their ... FuneralFinancials.com released a Must-Do List to help ... Funeral Financials recommends, “Creating a personal fact sheet.” , While ... organize financial information and personal data. It may include ...
(Date:5/25/2013)... 25, 2013 The latest report ... irritable bowel syndrome (IBS) to bloating, constipation, diarrhea ... most long-lasting, embarrassing, frustrating and difficult health issues ... digestive health have provided a cure for ... factors contributing to digestive health issues, a healthy ...
(Date:5/25/2013)... On May 25, Voices Against Brain ... advocacy, comments on a new study by the Max ... atmospheric plasma into brain cancer treatment may help when ... Science Daily article, physicists from the Max ... demonstrated the “synergistic effect of cold atmospheric plasma -- ...
(Date:5/25/2013)... Many orthodontists have thought about moving ... that cloud is. Most people would naturally assume ... provide their cloud service and support would own and ... they're selling, they'd be wrong. Cloud providers lease ... redundant facility that houses servers and related equipment to ...
(Date:5/25/2013)... 2013 According to world-renowned scholars, Queen ... powerful women that ever lived. Cleopatra’s legendary beauty moved ... the most powerful men in her time. Cleopatra was ... keep her skin glowing and fresh, from her legendary ... maringa oil and cyprus grass. , Cleopatra was said ...
Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
(Date:5/24/2013)... , May 24, 2013  Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...
(Date:5/24/2013)... In accordance with Rule 17.1 and Rule 2.9 ... United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") ... (NYSE: ELN). Background On 2 May ... for the entire of the issued and to be issued ... On 20 May 2013, Royalty Pharma announced ...
(Date:5/24/2013)... England and BOSTON , ... GPCR drug discovery and development company, is pleased to announce that ... a Consultant to augment the Company,s business development capabilities in ... Usui has more than 15 years of experience in business development, ... at Perlegen Sciences, Inc., Roche Pharma ( Japan ), ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
Cached News: